BRIEF-Immunovaccine awarded subcontract to evaluate depovax for development of malaria vaccine targets

Thu Jun 23, 2016 7:18am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

June 23 (Reuters) - Immunovaccine Inc

* Awarded a subcontract by leidos to evaluate immunovaccine's depovax(tm) platform for development of peptide based malaria vaccine targets Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)